Tranches exactly as the company dimensioned them in its 10-Q filed May 7, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Rough fully diluted estimate: 210.7M = 209.2M O/S + 1.5M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 7, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Registrations and offerings
F-3Mar 29, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
Last 12 months: 0 executed · 0 registered.
EFFECTIVEMay 31, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMar 29, 2024F-3 registration — capacity to sell shares, not a sale yetF-3 →
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.